Rejuvenating somatotropic signaling: A therapeutical opportunity for premature aging?

Aging

Volumn 2, Issue 12, 2010, Pages 1017-1022

  Ugalde, Alejandro P ^a   Mariño, Guillermo ^a   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Cancer; Growth hormone; Insulin like growth factor; Longevity; Progeria

Indexed keywords

GROWTH HORMONE; MEMBRANE PROTEIN; METALLOPROTEINASE; RECOMBINANT PROTEIN; SOMATOMEDIN C; ZMPSTE24 PROTEIN, MOUSE;

ANIMAL; ARTICLE; GENETICS; GENOTYPE; HUMAN; LONGEVITY; METABOLISM; MOUSE; MOUSE MUTANT; PHENOTYPE; PREMATURE AGING; PROGERIA; REJUVENATION; SIGNAL TRANSDUCTION;

AGING, PREMATURE; ANIMALS; GENOTYPE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; PHENOTYPE; PROGERIA; RECOMBINANT PROTEINS; REJUVENATION; SIGNAL TRANSDUCTION;

EID: 79952255626     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100262     Document Type: Article

References (38)

1. Vijg J and Campisi J. Puzzles, promises and a cure for ageing. Nature. 2008; 454: 1065-1071. www.impactaging.com 1020 AGING, December 2010, Vol.2 No.12
2. Blagosklonny MV, Campisi J, Sinclair DA. Aging: past, present and future. Aging. 2009; 1: 1-5.
3. Russell SJ and Kahn CR. Endocrine regulation of ageing. Nat Rev Mol Cell Biol. 2007; 8: 681-691.
4. Rozing MP, Westendorp RG, Frolich M, de Craen AJ, Beekman M, Heijmans BT, Mooijaart SP, Blauw GJ, Slagboom PE, van Heemst D. Human insulin/IGF-1 and familial longevity at middle age. Aging. 2009; 1: 714-722.
5. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 1993; 366: 461-464.
6. Liang H, Masoro EJ, Nelson JF, Strong R, McMahan CA, Richardson A. Genetic mouse models of extended lifespan. Exp Gerontol. 2003; 38: 1353-1364.
7. Bartke A. Growth hormone, insulin and aging: The benefits of endocrine defects. Exp Gerontol. 2010; In Press.
8. Guarente L and Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature. 2000; 408: 255-262.
9. Espada J, Varela I, Flores I, Ugalde AP, Cadinanos J, Pendas AM, Stewart CL, Tryggvason K, Blasco MA, Freije JM, Lopez-Otin C. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J Cell Biol. 2008; 181: 27-35.
10. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009; 460: 587-591.
11. Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL, Kockel L. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab. 2010; 11: 453-465.
12. Marino G, Fernandez AF, Lopez-Otin C. Autophagy and aging: lessons from progeria models. Adv Exp Med Biol. 2010; 694: 61-68.
13. Raffaello A and Rizzuto R. Mitochondrial longevity pathways. Biochim Biophys Acta. 2010;
14. Sahin E and Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010; 464: 520-528.
15. Haithcock E, Dayani Y, Neufeld E, Zahand AJ, Feinstein N, Mattout A, Gruenbaum Y, Liu J. Age-related changes of nuclear architecture in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2005; 102: 16690-16695.
16. Osorio FG, Obaya AJ, Lopez-Otin C, Freije JM. Accelerated ageing: from mechanism to therapy through animal models. Transgenic Res. 2009; 18: 7-15.
17. Pegoraro G and Misteli T. The central role of chromatin maintenance in aging. Aging. 2009; 1: 1017-1022.
18. Ramirez CL, Cadinanos J, Varela I, Freije JM, Lopez-Otin C. Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell Mol Life Sci. 2007; 64: 155-170.
19. Musich PR and Zou Y. Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A. Aging. 2009; 1: 28-37.
20. Burtner CR and Kennedy BK. Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol. 2010; 11: 567-578.
21. Osorio FG, Varela I, Lara E, Puente XS, Espada J, Santoro R, Freije JM, Fraga MF, Lopez-Otin C. Nuclear envelope alterations generate an aging-like epigenetic pattern in mice deficient in Zmpste24 metalloprotease. Aging Cell. 2010; 9: 947-957.
22. Hennekam RC. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A. 2006; 140: 2603-2624.
23. Pereira S, Bourgeois P, Navarro C, Esteves-Vieira V, Cau P, De Sandre-Giovannoli A, Levy N. HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches. Mech Ageing Dev. 2008; 129: 449-459.
24. Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol. 1999; 147: 913-920.
25. Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, Hultenby K, Astudillo A, Wernerson A, Rodriguez F, Tryggvason K, Lopez-Otin C. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet. 2002; 31: 94-99.
26. Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM, Zhou Z, Rodriguez FJ, Stewart CL, Vega JA, Tryggvason K, Freije JM, Lopez-Otin C. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature. 2005; 437: 564-568.
27. Marino G, Ugalde AP, Fernandez AF, Osorio FG, Fueyo A, Freije JM, Lopez-Otin C. Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function. Proc Natl Acad Sci U S A. 2010; 107: 16268-16273.
28. Abdenur JE, Brown WT, Friedman S, Smith M, Lifshitz F. Response to nutritional and growth hormone treatment in progeria. Metabolism. 1997; 46: 851-856.
29. Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, Russo MA, Cimino V, De Marinis L, Frustaci A, Catalucci D, Condorelli G. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation. 2009; 120: 2377-2385.
30. Marino G, Ugalde AP, Salvador-Montoliu N, Varela I, Quiros PM, Cadinanos J, van der Pluijm I, Freije JM, Lopez-Otin C. Premature aging in mice activates a systemic metabolic response involving autophagy induction. Hum Mol Genet. 2008; 17: 2196-2211.
31. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009; 361: 1475-1485.
32. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, Odijk H, Oostendorp R, Ahmad A, van Leeuwen W, Theil AF, Vermeulen W, van der Horst GT, Meinecke P, Kleijer WJ, Vijg J, Jaspers NG, Hoeijmakers JH. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature. 2006; 444: 1038-1043.
33. van der Pluijm I, Garinis GA, Brandt RM, Gorgels TG, Wijnhoven SW, Diderich KE, de Wit J, Mitchell JR, van Oostrom C, Beems R, Niedernhofer LJ, Velasco S, Friedberg EC, Tanaka K, van Steeg H, Hoeijmakers JH, van der Horst GT. Impaired genome maintenance suppresses the growth hormone-insulinlike growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol. 2007; 5: e2.
34. Garinis GA, Uittenboogaard LM, Stachelscheid H, Fousteri M, van Ijcken W, Breit TM, van Steeg H, Mullenders LH, van der Horst GT, Bruning JC, Niessen CM, Hoeijmakers JH, Schumacher B. Persistent transcription-blocking DNA lesions trigger somatic www.impactaging.com 1021 AGING, December 2010, Vol.2 No.12 growth attenuation associated with longevity. Nat Cell Biol. 2009; 11: 604-615.
35. Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein ML, Kopchick JJ, LeRoith D. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1- deficient mice. J Clin Invest. 2004; 113: 96-105.
36. Wolf E, Kahnt E, Ehrlein J, Hermanns W, Brem G, Wanke R. Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: lessons from transgenic animal models. Mech Ageing Dev. 1993; 68: 71-87.
37. Clemmons DR. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov. 2007; 6: 821-833.
38. Varela I, Pereira S, Ugalde AP, Navarro CL, Suarez MF, Cau P, Cadinanos J, Osorio FG, Foray N, Cobo J, de Carlos F, Levy N, Freije JM, Lopez-Otin C. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med. 2008; 14: 767-772.